Sulphacetamide + Chlorpheniramine Maleate
INFORMATION ABOUT SULPHACETAMIDE + CHLORPHENIRAMINE MALEATE
Sulphacetamide + Chlorpheniramine Maleate Uses
Sulphacetamide+Chlorpheniramine Maleate is used in the treatment of allergic eye disease.
How Sulphacetamide + Chlorpheniramine Maleate works
Sulphacetamide + Chlorpheniramine Maleate is a combination of two medicines:
Common side effects of Sulphacetamide + Chlorpheniramine Maleate
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common
Irritation, Burning sensation, Stinging sensation
CONTENT DETAILS
Last updated
25 Aug 2020 | 12:00 PM (UTC)
We provide you with authentic, trustworthy and revelant information
Read our editorial policy
Medicine brands for Sulphacetamide + Chlorpheniramine Maleate
Expert advice for Sulphacetamide + Chlorpheniramine Maleate
- Your doctor has prescribed Sulphacetamide + Chlorpheniramine Maleate to treat bacterial infections of the eye.
- Do not skip any doses and finish the full course of treatment even if you feel better.
- Apply pressure on the corner of the eye (close to the nose) for about 1 minute immediately after instilling the drop.
- If you wear soft contact lenses, remove them before putting in these eye drops and wait at least 15 minutes before putting your lenses back in.
- Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
- Burning sensation may occur for 1-2 mins. Notify your doctor if it persists for longer.
Frequently asked questions for Sulphacetamide + Chlorpheniramine Maleate
No, do not stop taking Sulphacetamide+Chlorpheniramine Maleate and complete the full course of treatment even if you feel better. Your symptoms may improve before the infection is completely cured.
Usually, Sulphacetamide+Chlorpheniramine Maleate starts working soon after applying it. However, it may take some days to kill all the harmful bacteria and make you feel better.